CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Baroda BNP Paribas Health and Wellness Fund-Reg(G)

very highequitypharma & health care
10.45 0.13(1.30%) NAV as on 03 Jul 2026
6.33 % 1 M
4.1 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.33

As on 31 Mar, 2026
age-icon Age :

1 yrs 0 m

Since 27 06 ,2025
exit_load Exit Load :

0%

aum AUM :

544.17 Crs

lock_in Lock-in :

NIL upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

9.25

Min_Investment Min. Investment :

SIP 500 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Sanjay Chawla,Rohan Korde

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2026
Others 2.59 %
Equity 97.41 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.09 %
Lupin Ltd.5.83 %
Laurus Labs Ltd.5.76 %
Abbott India Ltd.5.43 %
Torrent Pharmaceuticals Ltd.5.27 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs68.51
Hospital & Healthcare Services17.51
Insurance6.05
Retailing1.65
IT - Software1.54
See All Sectors

5-YEARS HISTORY

Financial Year2025-2026
NAV in Rs (as on 31-Mar-2026)9.10
Net Assets(Rs Crores) (as on 31-Mar-2026) 515.19
Scheme Returns(%)(Absolute)-8.96
B'mark Returns(%)(Absolute)NA
Category Rank98/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Baroda BNP Paribas Health and Wellness Fund-Reg(G)Very HighEquity10.450.13(1.30%)NAV As on 03 Jul, 202627-Jun-2025Inception Date544.17AUM In Cr.4.10%1YNA%3YNA%5Y4.47%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity43.570.47(1.09%)NAV As on 03 Jul, 202613-Jul-2018Inception Date6,453.52AUM In Cr.9.61%1Y26.21%3Y15.94%5Y20.26%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity501.114.86(0.98%)NAV As on 03 Jul, 202614-Jul-1999Inception Date4,565.95AUM In Cr.15.28%1Y25.03%3Y16.38%5Y16.31%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity44.330.59(1.35%)NAV As on 03 Jul, 202602-Jul-2018Inception Date3,090.51AUM In Cr.15.01%1Y24.31%3Y14.16%5Y20.44%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity35.370.46(1.32%)NAV As on 03 Jul, 202610-Jul-2019Inception Date950.31AUM In Cr.14.61%1Y23.08%3Y13.10%5Y19.82%Since Inception